Syndax Pharmaceuticals, Inc. Financial Ratios — SNDX Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-152.61	-132.73	-46.96	-44.71	-49.39	-66.9	-76.02	-40.18	6.64	-31.54	-37.72	-47.66	-45.5
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-5.01	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.47	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	100	100	100	100	100	100	100	- -	- -	96.51	95.96
EBITDA Margin (%)	- -	- -	- -	-3,268.26	-3,580.08	-2,935.39	-4,996.57	-3,786.88	-4,702.31	18.8	- -	- -	-1,434.39	-158.44
Operating Margin (%)	- -	- -	- -	-3,271.61	-3,587.38	-2,938.99	-5,001.71	-3,792.95	-4,708.17	18.77	- -	- -	-1,434.43	-158.45
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	70.66	127.39	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	-3,846.73	-3,645.25	-2,884.35	-4,875.48	-3,694.59	-4,822.54	17.84	- -	- -	-1,346.11	-165.6
Profit Margin (%)	- -	- -	- -	-3,846.73	-3,645.25	-2,884.35	-4,875.48	-3,694.59	-4,822.54	17.84	- -	- -	-1,346.11	-165.6
Net Income to Common Margin (%)	- -	- -	- -	-16,562.2	-3,858.2	-2,884.35	-4,875.48	-3,694.59	-4,822.54	17.84	- -	- -	-1,346.11	-165.6
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	60.64	24.77	76.77	5.52	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	21	- -	14	- -	- -	- -	- -	1	21	21	1	2	346	345
ST Debt	21	- -	6	- -	- -	- -	- -	- -	3	- -	- -	1	13	- -
LT Debt	- -	- -	7	- -	- -	- -	- -	- -	18	21	1	1	333	345
Total Debt/EBITDA	-2.45	- -	-0.65	- -	- -	- -	- -	-0.02	-0.29	0.8	-0.01	-0.01	-1.02	-1.26
Net Debt/EBITDA	-2.39	1.18	-0.18	1.13	0.55	0.57	0.45	0.43	1.33	-7.69	0.49	1.28	-0.56	-0.77
Total Debt/EBIT	-2.44	- -	-0.65	- -	- -	- -	- -	-0.02	-0.29	0.8	-0.01	-0.01	-1.02	-1.26
Net Debt/EBIT	-2.38	1.18	-0.18	1.13	0.54	0.57	0.45	0.43	1.33	-7.71	0.49	1.28	-0.56	-0.77
EBITDA to Interest Expense	- -	- -	- -	-13.01	- -	- -	- -	- -	-30.26	13.83	-48.37	-1,105.49	-68.9	-8.08
EBITDA-CapEx/Interest Expense	- -	- -	- -	-13.04	- -	- -	- -	- -	-30.26	13.76	-48.37	-1,105.49	-68.9	-8.09
EBIT to Interest Expense	- -	- -	- -	-13.02	- -	- -	- -	- -	-30.3	13.81	-48.38	-1,105.55	-68.9	-8.08
Interest Expense	- -	- -	- -	2	- -	- -	- -	- -	2	2	3	- -	5	34
Common Equity/Total Assets	-5,235.36	-795.42	-1,246.88	-288.84	-280.05	-266.87	-523.51	-779.96	-189.15	-120.91	-139.38	-147.24	-168.48	-284.42
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	1.33	7.11	5.05	0.15	0.11	115.62	533.75
Long-Term Debt/Capital (%)	- -	- -	91.03	- -	- -	- -	- -	-0.08	-3.27	-3.94	-0.1	-0.07	-38.06	-29.71
Long-Term Debt/Total Assets (%)	- -	- -	58.01	- -	- -	- -	- -	0.66	5.97	4.58	0.15	0.1	45.96	65.12
Total Debt/Equity (%)	-72.87	- -	-242.9	- -	- -	- -	- -	2.84	8.14	5.13	0.25	0.3	120	534.48
Total Debt/Capital (%)	-245.01	- -	169.98	- -	- -	- -	- -	-0.18	-3.75	-4.01	-0.17	-0.18	-39.49	-29.75
Total Debt/Total Assets (%)	1,413.44	- -	108.33	- -	- -	- -	- -	1.41	6.83	4.66	0.23	0.27	47.7	65.21
Net Debt to Equity	-71.04	-85.27	-67.79	-34.75	-28.34	-33.71	-63.66	-77.88	-37.72	-49.48	-15.91	-53.3	65.8	323.35
Net Debt/Capital (%)	-224.98	-579.03	-210.48	-53.3	7.24	8.76	7.14	4.74	14.34	27.13	9.7	24.7	-18.42	-16.12
EBITDA	-9	-9	-21	-20	-44	-62	-76	-57	-71	26	-152	-230	-340	-273
EBITDA-CapEx	-9	-9	-21	-21	-44	-62	-76	-57	-71	26	-152	-230	-340	-273
Operating Income (Loss)	-9	-9	-21	-21	-44	-62	-76	-58	-71	26	-152	-230	-340	-273

Liquidity (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.03	5.22	1.18	17.84	10.16	8.23	5.02	3.25	15.53	21.6	16.67	9.94	5.63	3.44
Current Ratio	0.03	5.33	1.2	18.16	10.47	8.45	5.18	3.39	15.84	21.68	16.85	10	5.82	4.4
Quick Ratio	0.03	5.22	1.18	17.9	10.19	8.25	5.04	3.26	15.54	21.62	16.81	9.96	5.76	4.03
CFO/Avg Current Liab	- -	-0.52	-2.2	-0.32	-4.62	-3.62	-4.3	-2.94	-3.83	1.47	-5.37	-3.69	-3.4	-2.89
Common Equity/Total Assets	-5,235.36	-795.42	-1,246.88	-288.84	-280.05	-266.87	-523.51	-779.96	-189.15	-120.91	-139.38	-147.24	-168.48	-284.42
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	1.33	7.11	5.05	0.15	0.11	115.62	533.75
Long-Term Debt/Capital (%)	- -	- -	91.03	- -	- -	- -	- -	-0.08	-3.27	-3.94	-0.1	-0.07	-38.06	-29.71
Long-Term Debt/Total Assets (%)	- -	- -	58.01	- -	- -	- -	- -	0.66	5.97	4.58	0.15	0.1	45.96	65.12
Total Debt/Equity (%)	-72.87	- -	-242.9	- -	- -	- -	- -	2.84	8.14	5.13	0.25	0.3	120	534.48
Total Debt/Capital (%)	-245.01	- -	169.98	- -	- -	- -	- -	-0.18	-3.75	-4.01	-0.17	-0.18	-39.49	-29.75
Total Debt/Total Assets (%)	1,413.44	- -	108.33	- -	- -	- -	- -	1.41	6.83	4.66	0.23	0.27	47.7	65.21
CFO/Total Liabilities	-30.14	-139.97	-77.67	-10.46	-141.34	-144.13	-221.85	-158.53	-147.16	70.55	-448.77	-273.67	-62.95	-69.45
CFO/CapEx	-844	-191.97	-3,598.25	-49.55	-134.7	-563.94	-366.48	- -	- -	225.82	- -	- -	- -	-1,727.17
Altman's Z-Score	-111.75	-11.96	-22.75	-3.68	-1.63	-0.82	-7.14	-8.02	9.07	16.51	29.3	13.27	-1.49	-2.09

Working Capital (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.23	7.56
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	58.59	48.28
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.51	0.42
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	80.87	867.2
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.11	2.79
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3,305.06	130.79
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-3,165.6	784.7
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-22.28	-818.92
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	33
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	29
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	- -	- -	105	184	113	268	919	1,140	1,546	1,521	1,132	1,820
- Cash & Cash Equivalents	1	10	10	23	24	35	34	25	115	222	74	295	154	135
+ Preferred Equity and Hybrid Capital	49	148	154	326	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	21	- -	14	- -	- -	- -	- -	1	21	21	1	2	346	345
Enterprise Value	70	133	156	240	-1	54	32	209	646	714	1,063	945	895	1,752
Total Capital	-9	12	8	67	-305	-366	-439	-495	-548	-523	-692	-901	-875	-1,161
Total Debt/Capital (%)	-245.01	- -	169.98	- -	- -	- -	- -	-0.18	-3.75	-4.01	-0.17	-0.18	-39.49	-29.75
Total Debt / EV	0.31	- -	0.09	- -	- -	- -	- -	- -	0.03	0.03	- -	- -	0.39	0.2
EV/Sales	- -	- -	- -	382.54	- -	25.6	21.09	137.66	425.95	5.11	- -	- -	37.79	10.16
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	27.18	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	27.22	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	23	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	22.91	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	105	184	113	268	919	1,140	1,546	1,521	1,132	1,820
Diluted Enterprise Value	70	137	158	303	81	149	79	244	824	939	1,473	1,227	1,324	2,031
EV per Share	0.99	16.65	16.23	13.81	- -	2.57	1.26	6.85	15.64	13.71	17.5	13.43	10.45	20.22
TTM Sales	- -	- -	- -	1	1	2	2	2	2	140	- -	- -	24	172
TTM EBITDA	-9	-9	-21	-20	-44	-62	-76	-57	-71	26	-152	-230	-340	-273
TTM Operating Income	-9	-9	-21	-21	-44	-62	-76	-58	-71	26	-152	-230	-340	-273
TTM Cash Flow to Firm	-9	-7	-14	-1	-35	-47	-69	-51	-69	31	-131	-160	-270	-289
TTM Free Cash Flow to Firm	-9	-7	-14	-1	-35	-47	-68	-51	-69	31	-131	-160	-270	-289

Multiples (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	- -	- -	-3	-3.89	-1.65	-5.29	-12.89	38.95	-11.57	-9.47	-4.12	-5.64
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	27.22	- -	- -	- -	- -
Enterprise Value	70	133	156	240	-1	54	32	209	646	714	1,063	945	895	1,752
Low Price	- -	- -	- -	- -	6.69	6.31	3.39	4.24	6.32	13.02	13.27	11.22	12.4	8.58
EV/Sales	- -	- -	- -	382.54	- -	25.6	21.09	137.66	425.95	5.11	- -	- -	37.79	10.16
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	27.18	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	45.72	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	-3.92	-3.8	-2.83	-4.02	-8.58	39.63	-8.08	-6.71	-5.43	-4.23
Price/Earnings High	- -	- -	- -	- -	-5.6	-5.42	-5.21	-6.04	-15.73	53.64	-10.79	-10.04	-6.81	-6.9
Price/Earnings Low	- -	- -	- -	- -	-2.08	-2.18	-1.16	-2.31	-3.57	27.2	-5.4	-3.77	-3.33	-2.6
Price/Book Value	- -	- -	- -	- -	-0.34	-0.5	-0.26	-0.54	-1.62	-2.1	-2.23	-1.69	-0.93	-1.21
Price/Book Value Average	- -	- -	- -	- -	-0.6	-0.63	-0.48	-0.45	-1.1	-1.82	-1.74	-1.56	-1.42	-0.8
Price/Book Value High	- -	- -	- -	- -	-0.86	-0.9	-0.88	-0.68	-2.02	-2.46	-2.32	-2.33	-1.78	-1.31
Price/Book Value Low	- -	- -	- -	- -	-0.32	-0.36	-0.2	-0.26	-0.46	-1.25	-1.16	-0.87	-0.87	-0.49
Price/Tangible Book Value	- -	- -	- -	- -	1.25	1.76	2.13	8.47	3.64	2.79	3.31	2.74	3.93	28.16
Price/Tangible Book Value Average	- -	- -	- -	- -	2.19	2.21	3.94	7.12	2.49	2.42	2.58	2.54	6.01	18.67
Price/Tangible Book Value High	- -	- -	- -	- -	3.13	3.16	7.27	10.72	4.56	3.27	3.45	3.79	7.53	30.47
Price/Tangible Book Value Low	- -	- -	- -	- -	1.16	1.27	1.62	4.09	1.04	1.66	1.72	1.42	3.68	11.5
Price/Sales	- -	- -	- -	- -	85.92	87.26	74.43	176.47	605.6	8.16	- -	- -	47.8	10.56
Price/Sales Average	- -	- -	- -	- -	151.1	109.52	137.91	148.36	413.75	7.07	- -	- -	73.13	7
Price/Sales High	- -	- -	- -	- -	216.06	156.38	254.22	223.3	758.36	9.57	- -	- -	91.62	11.42
Price/Sales Low	- -	- -	- -	- -	80.17	62.87	56.7	85.22	172.09	4.85	- -	- -	44.84	4.31
Price/Cash Flow	- -	- -	- -	- -	-2.98	-3.88	-1.65	-5.29	-12.89	39.12	-11.57	-9.47	-4.12	-5.64
Price/Cash Flow Average	- -	- -	- -	- -	-5.24	-4.87	-3.05	-4.45	-8.81	33.91	-9.02	-8.75	-6.3	-3.74
Price/Cash Flow High	- -	- -	- -	- -	-7.5	-6.96	-5.63	-6.69	-16.14	45.9	-12.05	-13.08	-7.89	-6.1
Price/Cash Flow Low	- -	- -	- -	- -	-2.78	-2.8	-1.26	-2.55	-3.66	23.27	-6.03	-4.91	-3.86	-2.3
Price/Free Cash Flow Average	- -	- -	- -	- -	-5.28	-4.88	-3.06	-4.45	-8.81	33.76	-9.02	-8.75	-6.3	-3.74
Price/Free Cash Flow High	- -	- -	- -	- -	-7.55	-6.97	-5.64	-6.69	-16.14	45.69	-12.05	-13.08	-7.89	-6.1
Price/Free Cash Flow Low	- -	- -	- -	- -	-2.8	-2.8	-1.26	-2.55	-3.66	23.17	-6.03	-4.91	-3.86	-2.3
EV/Sales Average	- -	- -	- -	483.52	131.56	92.83	115.65	132.73	351.32	5.63	- -	- -	81.22	8.22
EV/Sales High	- -	- -	- -	483.52	196.52	139.7	231.96	207.67	695.93	8.13	- -	- -	99.72	12.65
EV/Sales Low	- -	- -	- -	483.52	60.62	46.18	34.44	69.59	109.66	3.41	- -	- -	52.93	5.53
EV/EBITDA Average	-8.02	-16.06	-7.41	-14.79	-3.67	-3.16	-2.31	-3.51	-7.47	29.96	-7.47	-4.83	-5.66	-5.19
EV/EBITDA High	-8.02	-16.06	-7.41	-14.79	-5.49	-4.76	-4.64	-5.48	-14.8	43.26	-10.13	-7.86	-6.95	-7.98
EV/EBITDA Low	-8.02	-16.06	-7.41	-14.79	-1.69	-1.57	-0.69	-1.84	-2.33	18.16	-4.83	-2.15	-3.69	-3.49
EV/EBIT Average	-7.99	-16.04	-7.4	-14.78	-3.67	-3.16	-2.31	-3.5	-7.46	30.01	-7.46	-4.83	-5.66	-5.19
EV/EBIT High	-7.99	-16.04	-7.4	-14.78	-5.48	-4.75	-4.64	-5.48	-14.78	43.33	-10.13	-7.86	-6.95	-7.98
EV/EBIT Low	-7.99	-16.04	-7.4	-14.78	-1.69	-1.57	-0.69	-1.83	-2.33	18.19	-4.83	-2.15	-3.69	-3.49
Last Price	- -	- -	- -	- -	7.17	8.76	4.45	8.78	22.24	21.89	25.45	21.61	13.22	21.01
High Price	- -	- -	- -	- -	18.03	15.7	15.2	11.11	27.85	25.68	26.51	29.86	25.34	22.73
Enterprise Value Average	70	137	158	303	161	196	175	201	533	787	1,133	1,112	1,923	1,417
Enterprise Value High	70	137	158	303	240	294	352	315	1,056	1,136	1,538	1,808	2,361	2,180
Enterprise Value Low	70	137	158	303	74	97	52	106	166	477	733	495	1,253	954

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	17	17	17	17	18	24	25	27	48	55	68	85	86	87
Diluted Weighted Avg Shares	70	8	10	17	15	21	25	30	41	52	61	70	86	87
Basic Weighted Avg Shares	70	8	10	17	15	21	25	30	41	52	61	70	86	87
Revenue per Share	- -	- -	- -	0.04	0.08	0.1	0.06	0.05	0.04	2.68	- -	- -	0.28	1.99
EBITDA per Share	-0.12	-1.07	-2.22	-1.18	-2.99	-2.95	-2.99	-1.88	-1.73	0.5	-2.5	-3.27	-3.97	-3.15
Operating Income per Share	-0.12	-1.07	-2.22	-1.18	-2.99	-2.95	-2.99	-1.89	-1.73	0.5	-2.5	-3.27	-3.97	-3.15
Basic EPS, GAAP	-0.14	-4.5	-2.75	-5.98	-3.22	-2.9	-2.92	-1.84	-1.77	0.48	-2.46	-2.98	-3.72	-3.29
Basic EPS from Cont Ops	-0.14	-1.77	-2.07	-1.39	-3.04	-2.9	-2.92	-1.84	-1.77	0.48	-2.46	-2.98	-3.72	-3.29
Diluted EPS, GAAP	-0.14	-4.5	-2.75	-5.98	-3.22	-2.9	-2.92	-1.84	-1.77	0.48	-2.46	-2.98	-3.72	-3.29
Diluted EPS from Cont Ops	-0.14	-1.77	-2.07	-1.39	-3.04	-2.9	-2.92	-1.84	-1.77	0.48	-2.46	-2.98	-3.72	-3.29
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.13	-0.91	-1.5	-0.14	-2.4	-2.26	-2.7	-1.66	-1.73	0.56	-2.2	-2.28	-3.21	-3.73
Free Cash Flow per Basic Share	-0.13	-0.92	-1.5	-0.14	-2.42	-2.26	-2.71	-1.66	-1.73	0.56	-2.2	-2.28	-3.21	-3.73
Cash & Equivalents per Share	0.01	1.78	1.27	4.98	7.2	6.19	3.19	1.96	7.09	8.58	7.97	8.21	6.81	4.78
Book Value per Share	-1.12	-16.95	-16.65	-14.95	-20.88	-17.44	-17.32	-16.25	-13.77	-10.44	-11.41	-12.82	-14.26	-17.39
Tangible Book Value per Share	-1.11	-16.95	-16.65	-14.95	5.76	4.97	2.09	1.04	6.11	7.84	7.69	7.88	3.37	0.75

Syndax Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)